BBTV

About Us

Cancer Immunotherapy: A Long-Awaited Reality – Original Series Pilot

« 2010 End-of-the-Year Review, with Dennis Purcell
StemCells, Inc. – Panorama »

PILOT: Cancer Immunotherapy (Original Series)

This pilot was produced with the financial support of Celldex Therapeutics, Inc. – Sponsorships do not convey editorial privilege. BioBusiness.TV is an independent media.

Addressed in this pilot:

What is a cancer immunotherapy product? Are cancer vaccines preventive or therapeutic? Are we controlling or curing cancer? Will treatments be reimbursed? What is the economic rationale for cancer immunotherapy products? What are some of the promising products in the pipeline? Is immunotherapy now a reality in the treatment of cancer?


Future episodes will cover:

  • Understanding How the Immune System Works in Cancer
  • Clinical Considerations for Cancer Immunotherapy
  • Product Development
  • Wall Street Perspectives
  • Company Spotlights

Corporate sponsorships are available upon request.


Interviews conducted, on October 21st, 2010, in New York City.


Featured in this pilot (alphabetically):

  • David Berd, Cancer Treatment Centers of America
  • Martin A. “Mac” Cheever, University of Washington
  • Charles G. Drake, Johns Hopkins
  • Charles Duncan, JMP Securities
  • Michael Fanger, Dartmouth Medical School
  • Hervé Wolf Fridman, European Hospital Georges Pompidou, Cordeliers Research Centre
  • James Gulley, National Cancer Institute/National Institutes of Health
  • Tibor Keler, Celldex Therapeutics, Inc.
  • Michael Lotze, University of Pittsburgh Cancer Institute, Clinical and Translational Research Institute
  • Mark Monane, Needham & Co.
  • Charles Nicolette, Argos Therapeutics
  • Jill O’Donnell-Tormey, Cancer Research Institute (CRI)
  • Stelios Papadopoulos
  • Michael Sadelain, Memorial Sloan-Kettering Cancer Center
  • Joel Sendek, Lazard Capital Markets
  • Howard Soule, Prostate Cancer Foundation
  • David Urdal, Dendreon Corporation

A BioBusiness.TV Original Production

Produced by:

  • Jean-Loup Romet-Lemonne
  • Jonathan Teper

Associate Producers

  • Maury Raycroft
  • Heba Nowyhed

Director of Photography:

  • Andres Von Scheele

Related Videos:

  1. Cancer Immunotherapy : A Long Awaited Reality
  2. Cancer Immunotherapy Conference DVD Box Set
  3. Series Sponsorship
  4. Company Presentations : Cancer Immunotherapy
  5. Celldex Presentation at Cancer Immunotherapy Conference
  6. Cancer Immunotherapy (Best of the Web)
  7. Vaccinogen Presentation at Cancer Immunotherapy Conference
« 2010 End-of-the-Year Review, with Dennis Purcell
StemCells, Inc. – Panorama »

Post a Comment

Click here to cancel reply.

Your email is never published nor shared. Required fields are marked *

*
*
  • Sponsored by:


    Celldex Therapeutics

  • Related Videos

    1. Cancer Immunotherapy : A Long Awaited Reality
    2. Cancer Immunotherapy Conference DVD Box Set
    3. Series Sponsorship
    4. Company Presentations : Cancer Immunotherapy
    5. Celldex Presentation at Cancer Immunotherapy Conference
    6. Cancer Immunotherapy (Best of the Web)
    7. Vaccinogen Presentation at Cancer Immunotherapy Conference
  • ABOUT BIOBUSINESS.TV
  • BioBusiness.TV is the first independent Internet TV Network for biotechnology professionals. We create and syndicate video-based industry focused shows and series that range from scientific breakthroughs, to equity analyst insights, as well as C-level executive and investor interviews on strategy, management, policy, marketing, science and more. We strive to enhance the quality and accessibility of industry video programming, and to deliver information biotechnology professionals can rely on to make sound and informed decisions.

  • PARTNERING WITH BIOBUSINESS.TV
  • If you’ve got great video programs and a growing audience, let BioBusiness.TV help you take it to the next level through our Partner Program. You can reach out to us through our ‘contact us’ page.

  • DISCLAIMER
  • Viewers should verify all claims and do their own due diligence before investing in any securities mentioned on BioBusiness.TV.

  • COPYRIGHT © 2011 BIO BUSINESS TV, INC. All Rights Reserved